FMR LLC 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 10:16 am Purchase | 2025-07-31 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 13,101,596 10.900% | 1,954,643 (+17.54%) | Filing |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 11,146,954 9.400% | -1,268,688 (-10.22%) | Filing |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 12,415,642 10.518% | -592,141 (-4.55%) | Filing |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 13,007,783 13.265% | -401,460 (-2.99%) | Filing |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 13,409,243 14.162% | 819,408 (+6.51%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 12,589,835 14.999% | 4,101,153 (+48.31%) | Filing |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | Cytokinetics, Incorporated CYTK | FMR LLC | 8,488,682 11.832% | 5,864,957 (+223.54%) | Filing |